Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shahid Ghazi Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer specializing in the production of parenteral solutions and injectable medications. Established in 1984 and headquartered in Tabriz, the company is a leading producer of Large Volume Parenterals (LVP) and Small Volume Parenterals (SVP), including IV fluids, ampoules, and vials. Their extensive product portfolio includes electrolyte solutions, carbohydrates, antibiotics, and analgesics, produced under strict GMP standards. As a key subsidiary of Tamin Pharmaceutical Investment Company (TPICO), Shahid Ghazi plays a vital role in the Iranian healthcare system and exports its products to various regional markets. The company utilizes advanced Blow-Fill-Seal (BFS) technology to ensure high-quality aseptic manufacturing of its liquid products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shahid Ghazi Pharmaceutical Company.